{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:58:29Z","timestamp":1790697509862,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Many hypotheses have been postulated to define the etiology of sporadic Parkinson\u2019s and Alzheimer\u2019s disorders (PD and AD) but there is no consensus on what causes these devastating age-related diseases. Braak staging of both pathologies helped researchers to better understand the progression and to identify their prodromal and symptomatic phases. Indeed, it is well accepted that Lewy body pathology and neurofibrillary tangles appearance correlates with disease progression and severity of symptoms in PD and AD, respectively. Additionally, several studies in PD and AD models try to disclose which cellular mechanisms are defaulted and trigger the neurodegenerative process that culminates with neuronal death causing PD and AD classical symptomatology. Herein, we determined expression levels of proteins involved in microtubule assembly, autophagic-lysosomal pathway and unfolded protein response in the cortex, hippocampus and SNpc of PD and AD patients, vascular dementia patients and aged-match controls. The differential expression allowed us to determine which pathways are determinant to synaptic dysfunction and to establish a time line for disease progression. Our results allow us to challenge the hypothesis that both PD and AD pathologies are caused by \u03b1-synuclein or A\u03b2 pathology propagation throughout the brain in a prion-like manner.<\/jats:p>","DOI":"10.1038\/s41598-020-70174-z","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T10:04:15Z","timestamp":1596535455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Differential protein expression in diverse brain areas of Parkinson\u2019s and Alzheimer\u2019s disease patients"],"prefix":"10.1038","volume":"10","author":[{"given":"A. R.","family":"Esteves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"key":"70174_CR1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"70174_CR2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"70174_CR3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak, H., Ghebremedhin, E., Rub, U., Bratzke, H. & Del Tredici, K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 318, 121\u2013134 (2004).","journal-title":"Cell Tissue Res."},{"key":"70174_CR4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/1568007054546072","volume":"4","author":"SM Cardoso","year":"2005","unstructured":"Cardoso, S. M., Moreira, P. I., Agostinho, P., Pereira, C. & Oliveira, C. R. Neurodegenerative pathways in Parkinson\u2019s disease: therapeutic strategies. Curr. Drug Targets CNS Neurol. Disord. 4, 405\u2013419 (2005).","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"70174_CR5","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s12035-017-0420-y","volume":"55","author":"AR Esteves","year":"2018","unstructured":"Esteves, A. R. et al. Mitochondrial metabolism regulates microtubule acetylome and autophagy trough sirtuin-2: impact for Parkinson\u2019s disease. Mol. Neurobiol. 55, 1440\u20131462 (2018).","journal-title":"Mol. Neurobiol."},{"key":"70174_CR6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H. & Del Tredici, K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 112, 389\u2013404 (2006).","journal-title":"Acta Neuropathol."},{"key":"70174_CR7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/1568007054546117","volume":"4","author":"C Pereira","year":"2005","unstructured":"Pereira, C., Agostinho, P., Moreira, P. I., Cardoso, S. M. & Oliveira, C. R. Alzheimer\u2019s disease-associated neurotoxic mechanisms and neuroprotective strategies. Curr. Drug Targets CNS Neurol. Disord. 4, 383\u2013403 (2005).","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"70174_CR8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","volume":"57","author":"E Tonnies","year":"2017","unstructured":"Tonnies, E. & Trushina, E. Oxidative stress, synaptic dysfunction, and alzheimer\u2019s disease. J. Alzheimers Dis. 57, 1105\u20131121 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"70174_CR9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s004010050386","volume":"91","author":"L Claudio","year":"1996","unstructured":"Claudio, L. Ultrastructural features of the blood\u2013brain barrier in biopsy tissue from Alzheimer\u2019s disease patients. Acta Neuropathol. 91, 6\u201314 (1996).","journal-title":"Acta Neuropathol."},{"key":"70174_CR10","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1007\/s12035-016-9951-x","volume":"54","author":"DF Silva","year":"2017","unstructured":"Silva, D. F., Esteves, A. R., Oliveira, C. R. & Cardoso, S. M. Mitochondrial metabolism power SIRT2-dependent deficient traffic causing Alzheimer\u2019s-disease related pathology. Mol. Neurobiol. 54, 4021\u20134040 (2017).","journal-title":"Mol. Neurobiol."},{"key":"70174_CR11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-016-1571-z","volume":"131","author":"RN Kalaria","year":"2016","unstructured":"Kalaria, R. N. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer\u2019s disease. Acta Neuropathol. 131, 659\u2013685 (2016).","journal-title":"Acta Neuropathol."},{"key":"70174_CR12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0271678X15609542","volume":"36","author":"GA Rosenberg","year":"2016","unstructured":"Rosenberg, G. A. Vascular cognitive impairment: biomarkers in diagnosis and molecular targets in therapy. J. Cereb. Blood Flow Metab. 36, 4\u20135 (2016).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"70174_CR13","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/jcbfm.2013.159","volume":"33","author":"M Wiesmann","year":"2013","unstructured":"Wiesmann, M., Kiliaan, A. J. & Claassen, J. A. Vascular aspects of cognitive impairment and dementia. J. Cereb. Blood Flow Metab. 33, 1696\u20131706 (2013).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"70174_CR14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron 103, 627\u2013641 (2019) ((e627)).","journal-title":"Neuron"},{"key":"70174_CR15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/mds.27138","volume":"33","author":"P Borghammer","year":"2018","unstructured":"Borghammer, P. How does Parkinson\u2019s disease begin? Perspectives on neuroanatomical pathways, prions, and histology. Mov. Disord. 33, 48\u201357 (2018).","journal-title":"Mov. Disord."},{"key":"70174_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/B978-0-444-63945-5.00016-7","volume":"153","author":"LC Walker","year":"2018","unstructured":"Walker, L. C. Prion-like mechanisms in Alzheimer disease. Handb. Clin. neurol. 153, 303\u2013319 (2018).","journal-title":"Handb. Clin. neurol."},{"key":"70174_CR17","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.5664\/jcsm.7294","volume":"14","author":"M Wagner","year":"2018","unstructured":"Wagner, M., Raza, W., Esteves, A. R., Ryals, S. & Berry, R. A patient with suspicious oxygen desaturations at sleep onset. J. Clin. Sleep Med.: JCSM 14, 1435\u20131436 (2018).","journal-title":"J. Clin. Sleep Med.: JCSM"},{"key":"70174_CR18","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.bbadis.2018.11.014","volume":"1865","author":"AR Esteves","year":"2019","unstructured":"Esteves, A. R. et al. Acetylation as a major determinant to microtubule-dependent autophagy: relevance to Alzheimer\u2019s and Parkinson disease pathology. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 2008\u20132023 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"70174_CR19","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer, W. & Przedborski, S. Parkinson\u2019s disease: mechanisms and models. Neuron 39, 889\u2013909 (2003).","journal-title":"Neuron"},{"key":"70174_CR20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mito.2008.03.004","volume":"8","author":"AR Esteves","year":"2008","unstructured":"Esteves, A. R. et al. Mitochondrial function in Parkinson\u2019s disease cybrids containing an nt2 neuron-like nuclear background. Mitochondrion 8, 219\u2013228 (2008).","journal-title":"Mitochondrion"},{"key":"70174_CR21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin, M. T. & Beal, M. F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787\u2013795 (2006).","journal-title":"Nature"},{"key":"70174_CR22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuint.2009.04.004","volume":"55","author":"DM Arduino","year":"2009","unstructured":"Arduino, D. M., Esteves, A. R., Cardoso, S. M. & Oliveira, C. R. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson\u2019s disease. Neurochem. Int. 55, 341\u2013348 (2009).","journal-title":"Neurochem. Int."},{"key":"70174_CR23","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.brainres.2016.03.044","volume":"1648","author":"N Ogen-Shtern","year":"2016","unstructured":"Ogen-Shtern, N., Ben David, T. & Lederkremer, G. Z. Protein aggregation and ER stress. Brain Res. 1648, 658\u2013666 (2016).","journal-title":"Brain Res."},{"key":"70174_CR24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.tins.2018.09.007","volume":"42","author":"ME Johnson","year":"2019","unstructured":"Johnson, M. E., Stecher, B., Labrie, V., Brundin, L. & Brundin, P. Triggers, facilitators, and aggravators: redefining Parkinson\u2019s disease pathogenesis. Trends Neurosci. 42, 4\u201313 (2019).","journal-title":"Trends Neurosci."},{"key":"70174_CR25","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1093\/hmg\/dds309","volume":"21","author":"DM Arduino","year":"2012","unstructured":"Arduino, D. M. et al. Mitochondrial metabolism in Parkinson\u2019s disease impairs quality control autophagy by hampering microtubule-dependent traffic. Hum. Mol. Genet. 21, 4680\u20134702 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"70174_CR26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbadis.2013.10.003","volume":"1842","author":"AR Esteves","year":"2014","unstructured":"Esteves, A. R., Gozes, I. & Cardoso, S. M. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson\u2019s disease. Biochim. Biophys. Acta 1842, 7\u201321 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"70174_CR27","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/srep01837","volume":"3","author":"D Cartelli","year":"2013","unstructured":"Cartelli, D. et al. Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotective. Sci. Rep. 3, 1837 (2013).","journal-title":"Sci. Rep."},{"key":"70174_CR28","doi-asserted-by":"crossref","first-page":"34105","DOI":"10.1074\/jbc.M503483200","volume":"280","author":"Y Ren","year":"2005","unstructured":"Ren, Y., Liu, W., Jiang, H., Jiang, Q. & Feng, J. Selective vulnerability of dopaminergic neurons to microtubule depolymerization. J. Biol. Chem. 280, 34105\u201334112 (2005).","journal-title":"J. Biol. Chem."},{"key":"70174_CR29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4161\/auto.6458","volume":"4","author":"RK Dagda","year":"2008","unstructured":"Dagda, R. K., Zhu, J., Kulich, S. M. & Chu, C. T. Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: implications for Parkinson\u2019s disease. Autophagy 4, 770\u2013782 (2008).","journal-title":"Autophagy"},{"key":"70174_CR30","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1242\/jcs.011163","volume":"120","author":"Y Chen","year":"2007","unstructured":"Chen, Y., McMillan-Ward, E., Kong, J., Israels, S. J. & Gibson, S. B. Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J. Cell Sci. 120, 4155\u20134166 (2007).","journal-title":"J. Cell Sci."},{"key":"70174_CR31","first-page":"25","volume":"12","author":"P Anglade","year":"1997","unstructured":"Anglade, P. et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson\u2019s disease. Histol. Histopathol. 12, 25\u201331 (1997).","journal-title":"Histol. Histopathol."},{"key":"70174_CR32","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","volume":"67","author":"L Alvarez-Erviti","year":"2010","unstructured":"Alvarez-Erviti, L. et al. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch. Neurol. 67, 1464\u20131472 (2010).","journal-title":"Arch. Neurol."},{"key":"70174_CR33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","volume":"35","author":"Y Chu","year":"2009","unstructured":"Chu, Y., Dodiya, H., Aebischer, P., Olanow, C. W. & Kordower, J. H. Alterations in lysosomal and proteasomal markers in Parkinson\u2019s disease: relationship to alpha-synuclein inclusions. Neurobiol. Dis. 35, 385\u2013398 (2009).","journal-title":"Neurobiol. Dis."},{"key":"70174_CR34","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton, L. K., Blurton-Jones, M., Myczek, K., Trojanowski, J. Q. & LaFerla, F. M. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J. Neurosci. 30, 7281\u20137289 (2010).","journal-title":"J. Neurosci."},{"key":"70174_CR35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-007-0336-0","volume":"115","author":"T Lashley","year":"2008","unstructured":"Lashley, T. et al. Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson\u2019s disease patients. Acta Neuropathol. 115, 417\u2013425 (2008).","journal-title":"Acta Neuropathol."},{"key":"70174_CR36","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.0000000000003840","volume":"88","author":"L Rochester","year":"2017","unstructured":"Rochester, L. et al. Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease. Neurology 88, 1501\u20131511 (2017).","journal-title":"Neurology"},{"key":"70174_CR37","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1093\/hmg\/ddi396","volume":"14","author":"WW Smith","year":"2005","unstructured":"Smith, W. W. et al. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum. Mol. Genet. 14, 3801\u20133811 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"70174_CR38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","volume":"313","author":"AA Cooper","year":"2006","unstructured":"Cooper, A. A. et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson\u2019s models. Science 313, 324\u2013328 (2006).","journal-title":"Science"},{"key":"70174_CR39","doi-asserted-by":"crossref","first-page":"10690","DOI":"10.1523\/JNEUROSCI.22-24-10690.2002","volume":"22","author":"EJ Ryu","year":"2002","unstructured":"Ryu, E. J. et al. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson\u2019s disease. J. Neurosci. 22, 10690\u201310698 (2002).","journal-title":"J. Neurosci."},{"key":"70174_CR40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2007.01.043","volume":"354","author":"JJ Hoozemans","year":"2007","unstructured":"Hoozemans, J. J. et al. Activation of the unfolded protein response in Parkinson\u2019s disease. Biochem. Biophys. Res. Commun. 354, 707\u2013711 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"70174_CR41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","volume":"64","author":"RA Nixon","year":"2005","unstructured":"Nixon, R. A. et al. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J. Neuropathol. Exp. Neurol. 64, 113\u2013122 (2005).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"70174_CR42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neurobiolaging.2006.09.005","volume":"29","author":"L Urbanelli","year":"2008","unstructured":"Urbanelli, L. et al. Cathepsin D expression is decreased in Alzheimer\u2019s disease fibroblasts. Neurobiol. Aging 29, 12\u201322 (2008).","journal-title":"Neurobiol. Aging"},{"key":"70174_CR43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1750-1326-7-59","volume":"7","author":"M Torres","year":"2012","unstructured":"Torres, M. et al. Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP\/PS1 hippocampus. Mol. Neurodegener. 7, 59 (2012).","journal-title":"Mol. Neurodegener."},{"key":"70174_CR44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1046\/j.1471-4159.1995.64010443.x","volume":"64","author":"AL Schwagerl","year":"1995","unstructured":"Schwagerl, A. L. et al. Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease. J. Neurochem. 64, 443\u2013446 (1995).","journal-title":"J. Neurochem."},{"key":"70174_CR45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bpa.12631","volume":"29","author":"YL Chai","year":"2019","unstructured":"Chai, Y. L. et al. Lysosomal cathepsin D is upregulated in Alzheimer\u2019s disease neocortex and may be a marker for neurofibrillary degeneration. Brain Pathol. 29, 63\u201374 (2019).","journal-title":"Brain Pathol."},{"key":"70174_CR46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/WNL.0000000000001702","volume":"85","author":"EJ Goetzl","year":"2015","unstructured":"Goetzl, E. J. et al. Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology 85, 40\u201347 (2015).","journal-title":"Neurology"},{"key":"70174_CR47","first-page":"2190","volume":"118","author":"F Pickford","year":"2008","unstructured":"Pickford, F. et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 118, 2190\u20132199 (2008).","journal-title":"J. Clin. Invest."},{"key":"70174_CR48","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1471-4159.2004.02438.x","volume":"89","author":"SM Cardoso","year":"2004","unstructured":"Cardoso, S. M., Santana, I., Swerdlow, R. H. & Oliveira, C. R. Mitochondria dysfunction of Alzheimer\u2019s disease cybrids enhances Abeta toxicity. J. Neurochem. 89, 1417\u20131426 (2004).","journal-title":"J. Neurochem."},{"key":"70174_CR49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00401-011-0896-x","volume":"123","author":"R Sanchez-Varo","year":"2012","unstructured":"Sanchez-Varo, R. et al. Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer\u2019s mice hippocampus. Acta Neuropathol. 123, 53\u201370 (2012).","journal-title":"Acta Neuropathol."},{"key":"70174_CR50","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-2011-110423","volume":"26","author":"DF Silva","year":"2011","unstructured":"Silva, D. F., Esteves, A. R., Arduino, D. M., Oliveira, C. R. & Cardoso, S. M. Amyloid-beta-induced mitochondrial dysfunction impairs the autophagic lysosomal pathway in a tubulin dependent pathway. J. Alzheimers Dis. 26, 565\u2013581 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"70174_CR51","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0002-9440(10)64296-4","volume":"162","author":"AD Cash","year":"2003","unstructured":"Cash, A. D. et al. Microtubule reduction in Alzheimer\u2019s disease and aging is independent of tau filament formation. Am. J. Pathol. 162, 1623\u20131627 (2003).","journal-title":"Am. J. Pathol."},{"key":"70174_CR52","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-3-7091-6467-9_12","volume":"53","author":"RD Terry","year":"1998","unstructured":"Terry, R. D. The cytoskeleton in Alzheimer disease. J. Neural Transm. Suppl. 53, 141\u2013145 (1998).","journal-title":"J. Neural Transm. Suppl."},{"key":"70174_CR53","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/00005072-199609000-00003","volume":"55","author":"B Hempen","year":"1996","unstructured":"Hempen, B. & Brion, J. P. Reduction of acetylated alpha-tubulin immunoreactivity in neurofibrillary tangle-bearing neurons in Alzheimer\u2019s disease. J. Neuropathol. Exp. Neurol. 55, 964\u2013972 (1996).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"70174_CR54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/nan.12084","volume":"40","author":"S Mondragon-Rodriguez","year":"2014","unstructured":"Mondragon-Rodriguez, S., Perry, G., Luna-Munoz, J., Acevedo-Aquino, M. C. & Williams, S. Phosphorylation of tau protein at sites Ser(396\u2013404) is one of the earliest events in Alzheimer\u2019s disease and Down syndrome. Neuropathol. Appl. Neurobiol. 40, 121\u2013135 (2014).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"70174_CR55","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.nbd.2006.05.011","volume":"23","author":"E Ferreiro","year":"2006","unstructured":"Ferreiro, E., Resende, R., Costa, R., Oliveira, C. R. & Pereira, C. M. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiol. Dis. 23, 669\u2013678 (2006).","journal-title":"Neurobiol. Dis."},{"key":"70174_CR56","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00401-005-1038-0","volume":"110","author":"JJ Hoozemans","year":"2005","unstructured":"Hoozemans, J. J. et al. The unfolded protein response is activated in Alzheimer\u2019s disease. Acta Neuropathol. 110, 165\u2013172 (2005).","journal-title":"Acta Neuropathol."},{"key":"70174_CR57","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1083\/jcb.200711066","volume":"182","author":"S Song","year":"2008","unstructured":"Song, S. et al. E2-25K\/Hip-2 regulates caspase-12 in ER stress-mediated Abeta neurotoxicity. J. Cell Biol. 182, 675\u2013684 (2008).","journal-title":"J. Cell Biol."},{"key":"70174_CR58","doi-asserted-by":"crossref","first-page":"18434","DOI":"10.1074\/jbc.RA118.005769","volume":"293","author":"KR Sadleir","year":"2018","unstructured":"Sadleir, K. R., Popovic, J. & Vassar, R. ER stress is not elevated in the 5XFAD mouse model of Alzheimer\u2019s disease. J. Biol. Chem. 293, 18434\u201318443 (2018).","journal-title":"J. Biol. Chem."},{"key":"70174_CR59","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/jnen\/nly070","volume":"77","author":"Y Takaichi","year":"2018","unstructured":"Takaichi, Y. et al. Deposition of phosphorylated alpha-synuclein in the rTg4510 mouse model of tauopathy. J. Neuropathol. Exp. Neurol. 77, 920\u2013928 (2018).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"70174_CR60","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0006-8993(99)02207-6","volume":"853","author":"F Yang","year":"2000","unstructured":"Yang, F., Ueda, K., Chen, P., Ashe, K. H. & Cole, G. M. Plaque-associated alpha-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein. Brain Res. 853, 381\u2013383 (2000).","journal-title":"Brain Res."},{"issue":"Suppl 1","key":"70174_CR61","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.parkreldis.2003.11.005","volume":"10","author":"S Kim","year":"2004","unstructured":"Kim, S., Seo, J. H. & Suh, Y. H. Alpha-synuclein, Parkinson\u2019s disease, and Alzheimer\u2019s disease. Parkinsonism Relat. Disord. 10(Suppl 1), S9-13 (2004).","journal-title":"Parkinsonism Relat. Disord."},{"key":"70174_CR62","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1749-6632.2002.tb04807.x","volume":"977","author":"AD Korczyn","year":"2002","unstructured":"Korczyn, A. D. Mixed dementia\u2014the most common cause of dementia. Ann. N. Y. Acad. Sci. 977, 129\u2013134 (2002).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"70174_CR63","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/NEN.0000000000000157","volume":"74","author":"EB Mukaetova-Ladinska","year":"2015","unstructured":"Mukaetova-Ladinska, E. B. et al. Tau proteins in the temporal and frontal cortices in patients with vascular dementia. J. Neuropathol. Exp. Neurol. 74, 148\u2013157 (2015).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"70174_CR64","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/jnr.23925","volume":"94","author":"V Calabrese","year":"2016","unstructured":"Calabrese, V. et al. Major pathogenic mechanisms in vascular dementia: roles of cellular stress response and hormesis in neuroprotection. J. Neurosci. Res. 94, 1588\u20131603 (2016).","journal-title":"J. Neurosci. Res."},{"key":"70174_CR65","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ana.25399","volume":"85","author":"JS Rabin","year":"2019","unstructured":"Rabin, J. S. et al. Vascular risk and beta-amyloid are synergistically associated with cortical tau. Ann. Neurol. 85, 272\u2013279 (2019).","journal-title":"Ann. Neurol."},{"key":"70174_CR66","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/bpa.12769","volume":"30","author":"Y Hase","year":"2019","unstructured":"Hase, Y. et al. Small vessel disease pathological changes in neurodegenerative and vascular dementias concomitant with autonomic dysfunction. Brain Pathol. 30, 191\u2013202 (2019).","journal-title":"Brain Pathol."},{"key":"70174_CR67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.psychres.2018.06.012","volume":"267","author":"DP Wang","year":"2018","unstructured":"Wang, D. P. et al. The potential protective effects of cannabinoid receptor agonist WIN55,212\u20132 on cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia. Psychiatry Res. 267, 281\u2013288 (2018).","journal-title":"Psychiatry Res."},{"key":"70174_CR68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fnins.2017.00058","volume":"11","author":"KI Tanaka","year":"2017","unstructured":"Tanaka, K. I. & Kawahara, M. Copper enhances zinc-induced neurotoxicity and the endoplasmic reticulum stress response in a neuronal model of vascular dementia. Front. Neurosci. 11, 58 (2017).","journal-title":"Front. Neurosci."},{"key":"70174_CR69","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1002\/jcp.27332","volume":"234","author":"XL Niu","year":"2019","unstructured":"Niu, X. L. et al. DL-3-n-butylphthalide alleviates vascular cognitive impairment by regulating endoplasmic reticulum stress and the Shh\/Ptch1 signaling-pathway in rats. J. Cell Physiol. 234, 12604\u201312614 (2019).","journal-title":"J. Cell Physiol."},{"key":"70174_CR70","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/nen.0b013e31802c3e7d","volume":"66","author":"I Ferrer","year":"2007","unstructured":"Ferrer, I. et al. Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe Study. J. Neuropathol. Exp. Neurol. 66, 35\u201346 (2007).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"70174_CR71","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0003-2697(81)90281-5","volume":"112","author":"WN Burnette","year":"1981","unstructured":"Burnette, W. N. \u201cWestern blotting\u201d: electrophoretic transfer of proteins from sodium dodecyl sulfate\u2013polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112, 195\u2013203 (1981).","journal-title":"Anal. Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70174-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T15:16:47Z","timestamp":1670339807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70174-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["70174"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-70174-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,4]]},"assertion":[{"value":"3 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13149"}}